ArriVent BioPharma Inc (AVBP)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
| Quarter End | Dec 2023 | Mar 2024 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Assets | 163.1M | 327.84M |
| Total Current Assets | 159.97M | 327.48M |
| Cash and Equivalents | 150.39M | 317.39M |
| Total Non-Current Assets | 3.13M | 358k |
| Total Liabilities | 11.8M | 10.12M |
| Total Current Liabilities | 11.62M | 9.98M |
| Total Non-Current Liabilities | 177k | 138k |
| Common Equity | 0 | 3k |
| Retained Earnings | -157.85M | -175.26M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Assets | 182.83M | 163.1M |
| Total Current Assets | 182.62M | 159.97M |
| Cash and Equivalents | 163.37M | 150.39M |
| Total Non-Current Assets | -85.11M | -153.19M |
| Total Liabilities | 8.37M | 11.8M |
| Total Current Liabilities | 8.36M | 11.62M |
| Total Non-Current Liabilities | 11k | 177k |
| Total Equity | -85.11M | -153.19M |
| Common Equity | 4k | 0 |
| Retained Earnings | -88.51M | -157.85M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
